Introduction: Chronic subdural hematoma (CSDH) is characterized by the collection of blood beneath the dura mater. Traditional treatments involve surgical drainage of the hematoma, but recurrence rates can be high. A highly vascularized neo-membrane irrigated by the middle meningeal artery (MMA) may be involved in CSDH re-accumulation. We conducted a systematic review and meta-analysis of studies that compared the efficacy and safety of MMA embolization to conventional treatment alone for CSDH. Methods: A systematic search of PubMed, Embase Ovid, and ClinicalTrials.gov identified observational and randomized clinical studies comparing MMA embolization to conventional treatment for CSDH. The efficacy outcomes were hematoma recurrence and good functional outcome (as defined by a modified Rankin Scale Score [mRS] of 0–2). Safety outcomes were the rate of major complication and mortality. Heterogeneity among studies were evaluated using the I2 statistic. Analyses were conducted using Cochrane Review Manager Software, with risk ratios (RRs) and 95% confidence intervals (95% CI) presented for key outcomes. Absolute risk reduction (95% CI) of 1,000 patients was also calculated using GRADEpro software. Results: The analysis included data from 13 studies (4 randomized clinical trials [RCTs] and 9 observational studies) with a total number of 2,960 patients (35.3% in the MMA group and 64.7% in the conventional treatment group). Compared to conventional treatment, MMA embolization decreased risk of hematoma recurrence by 59% (13 studies, RR = 0.41, 95% CI: 0.26–0.65; I2 = 49%), for an absolute effect of 116 fewer events/1,000 patients (95% CI: 69–145), with similar risk of major complications (13 studies, RR = 0.88, 95% CI: 0.67–1.15; I2 = 43%) and mortality risk (13 studies, RR = 1.05, 95% CI: 0.67–1.65). In subgroup analyses by study type, pooled results from RCTs showed similar direction effects as those from observational studies for both efficacy and safety outcomes. Conclusion: MMA embolization in CSDH management is a safe and effective approach for CSDH.

1.
Feghali
J
,
Yang
W
,
Huang
J
.
Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome
.
World Neurosurg
.
2020
;
141
:
339
45
.
2.
Rauhala
M
,
Helén
P
,
Huhtala
H
,
Heikkilä
P
,
Iverson
GL
,
Niskakangas
T
, et al
.
Chronic subdural hematoma: incidence, complications, and financial impact
.
Acta Neurochir
.
2020
;
162
(
9
):
2033
43
.
3.
Balser
D
,
Farooq
S
,
Mehmood
T
,
Reyes
M
,
Samadani
U
.
Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations
.
JNS
.
2015
;
123
(
5
):
1209
15
.
4.
Ducruet
AF
,
Grobelny
BT
,
Zacharia
BE
,
Hickman
ZL
,
DeRosa
PL
,
Andersen
KN
, et al
.
The surgical management of chronic subdural hematoma
.
Neurosurg Rev
.
2012
;
35
(
2
):
155
69
.
5.
Ironside
N
,
Nguyen
C
,
Do
Q
,
Ugiliweneza
B
,
Chen
CJ
,
Sieg
EP
, et al
.
Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis
.
J Neurointerv Surg
.
2021
;
13
(
10
):
951
7
.
6.
Davies
J
,
Knopman
J
.
ClinicalTrials.gov. 2024. Embolization of the middle meningeal artery with ONYXTM liquid embolic system for subacute and chronic subdural hematoma (EMBOLISE)
. Available from: https://clinicaltrials.gov/study/NCT04402632?tab=history&a=9#study-details-card
7.
Liberati
A
,
Altman
DG
,
Tetzlaff
J
,
Mulrow
C
,
Gøtzsche
PC
,
Ioannidis
JPA
, et al
.
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
.
J Clin Epidemiol
.
2009
;
62
(
10
):
e1
34
.
8.
Fiorella
D
,
Monteith
SJ
,
Hanel
R
,
Atchie
B
,
Boo
S
,
McTaggart
RA
, et al
.
Embolization of the middle meningeal artery for chronic subdural hematoma
.
N Engl J Med
.
2024
.
9.
Davies
JM
,
Knopman
J
,
Mokin
M
,
Hassan
AE
,
Harbaugh
RE
,
Khalessi
A
, et al
.
Adjunctive middle meningeal artery embolization for subdural hematoma
.
N Engl J Med
.
2024
;
391
(
20
):
1890
900
.
10.
Liu
J
,
Ni
W
,
Zuo
Q
,
Yang
H
,
Peng
Y
,
Lin
Z
, et al
.
Middle meningeal artery embolization for nonacute subdural hematoma
.
N Engl J Med
.
2024
;
391
(
20
):
1901
12
.
11.
Onyinzo
C
,
Berlis
A
,
Abel
M
,
Kudernatsch
M
,
Maurer
CJ
.
Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone
.
J Neurointerv Surg
.
2022
;
14
(
3
):
297
300
.
12.
Enriquez-Marulanda
A
,
Gomez-Paz
S
,
Salem
MM
,
Mallick
A
,
Motiei-Langroudi
R
,
Arle
JE
, et al
.
Middle meningeal artery embolization versus conventional treatment of chronic subdural hematomas
.
Neurosurg
.
2021
;
89
(
3
):
486
95
.
13.
Catapano
JS
,
Ducruet
AF
,
Nguyen
CL
,
Cole
TS
,
Baranoski
JF
,
Majmundar
N
, et al
.
A propensity-adjusted comparison of middle meningeal artery embolization versus conventional therapy for chronic subdural hematomas
.
J Neurosurg
.
2021
;
135
(
4
):
1208
13
.
14.
Shotar
E
,
Meyblum
L
,
Premat
K
,
Lenck
S
,
Degos
V
,
Grand
T
, et al
.
Middle meningeal artery embolization reduces the post-operative recurrence rate of at-risk chronic subdural hematoma
.
J Neurointerv Surg
.
2020
;
12
(
12
):
1209
13
.
15.
Ng
S
,
Derraz
I
,
Boetto
J
,
Dargazanli
C
,
Poulen
G
,
Gascou
G
, et al
.
Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption
.
J Neurointerv Surg
.
2020
;
12
(
7
):
695
9
.
16.
Ban
SP
,
Hwang
G
,
Byoun
HS
,
Kim
T
,
Lee
SU
,
Bang
JS
, et al
.
Middle meningeal artery embolization for chronic subdural hematoma
.
Radiology
.
2018
;
286
(
3
):
992
9
.
17.
Matsumoto
H
,
Hanayama
H
,
Okada
T
,
Sakurai
Y
,
Minami
H
,
Masuda
A
, et al
.
Which surgical procedure is effective for refractory chronic subdural hematoma? Analysis of our surgical procedures and literature review
.
J Clin Neurosci
.
2018
;
49
:
40
7
.
18.
Kim
E
.
Embolization therapy for refractory hemorrhage in patients with chronic subdural hematomas
.
World Neurosurg
.
2017
;
101
:
520
7
.
19.
Salih
M
,
Shutran
M
,
Young
M
,
Vega
RA
,
Stippler
M
,
Papavassiliou
E
, et al
.
Reduced recurrence of chronic subdural hematomas treated with open surgery followed by middle meningeal artery embolization compared to open surgery alone: a propensity score–matched analysis
.
J Neurosurg
.
2023
;
139
(
1
):
124
30
.
20.
Carpenter
A
,
Rock
M
,
Dowlati
E
,
Miller
C
,
Mai
JC
,
Liu
AH
, et al
.
Middle meningeal artery embolization with subdural evacuating port system for primary management of chronic subdural hematomas
.
Neurosurg Rev
.
2022
;
45
(
1
):
439
49
.
21.
Lam
A
,
Selvarajah
D
,
Htike
SS
,
Chan
S
,
Lalloo
S
,
Lock
G
, et al
.
The efficacy of postoperative middle meningeal artery embolization on chronic subdural hematoma: a multicentered randomized controlled trial
.
Surg Neurol Int
.
2023
;
14
:
168
.
22.
Sterne
JAC
,
Savović
J
,
Page
MJ
,
Elbers
RG
,
Blencowe
NS
,
Boutron
I
, et al
.
RoB 2: a revised tool for assessing risk of bias in randomised trials
.
BMJ
.
2019
;
366
:
l4898
.
23.
Sterne
JA
,
Hernán
MA
,
Reeves
BC
,
Savović
J
,
Berkman
ND
,
Viswanathan
M
, et al
.
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
.
BMJ
.
2016
;
355
:
i4919
.
24.
Rao
G
,
Lopez-Jimenez
F
,
Boyd
J
,
D’Amico
F
,
Durant
NH
,
Hlatky
MA
, et al
.
Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: a scientific statement from the American Heart association
.
Circulation
.
2017
;
136
(
10
):
e172
94
.
25.
Review Manager (RevMan) [Computer program] Version 5.4
.
The Cochrane Collaboration
;
2020
. [n.d].
27.
Kolias
AG
,
Chari
A
,
Santarius
T
,
Hutchinson
PJ
.
Chronic subdural haematoma: modern management and emerging therapies
.
Nat Rev Neurol
.
2014
;
10
(
10
):
570
8
.
28.
Atefi
N
,
Alcock
S
,
Silvaggio
JA
,
Shankar
J
.
Clinical outcome and recurrence risk of chronic subdural hematoma after surgical drainage
.
Cureus
.
2023
;
15
(
2
):
e35525
.
29.
Désir
LL
,
D’Amico
R
,
Link
T
,
Silva
D
,
Ellis
JA
,
Doron
O
, et al
.
Middle meningeal artery embolization and the treatment of a chronic subdural hematoma
.
Cureus
.
2021
;
13
(
10
):
e18868
.
30.
Gerstl
J
,
Shafi
M
,
Badikol
S
,
Nawabi
N
,
Mekary
R
,
Sukumaran
M
, et al
.
E-049 Complications of middle meningeal artery embolization: a systematic review
.
SNIS 20th annual meeting electronic poster abstracts [Internet]
.
BMJ Publishing Group Ltd
;
2023
. Available from: https://jnis.bmj.com/lookup/doi/10.1136/jnis-2023-SNIS.149
31.
Sattari
SA
,
Yang
W
,
Shahbandi
A
,
Feghali
J
,
Lee
RP
,
Xu
R
, et al
.
Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: a systematic review and meta-analysis
.
Neurosurgery
.
2023
;
92
(
6
):
1142
54
.
32.
Lu
H
,
Cole
SR
,
Howe
CJ
,
Westreich
D
.
Toward a clearer definition of selection bias when estimating causal effects
.
Epidemiology
.
2022
;
33
(
5
):
699
706
.
33.
Kabir
N
,
Owais
B
,
Trifan
G
,
Testai
F
.
Efficacy and safety of middle meningeal artery embolization for patients with chronic subdural hematoma: a systematic review and meta-analysis
.
Cerebrovasc Dis
.
2024
;
1
13
.
You do not currently have access to this content.